Kanamycin
An aminoglycoside antibiotic.
General information
Kanamycin on PubChem
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N
Supporting references
| Link | Tested on | Impact factor | Notes | Publication date |
|---|---|---|---|---|
|
Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design
3CLpro Small molecule In silico Screening |
in silico | 1.85 | Predicted to inhibit SARS-CoV-2 3C-like protease. |
Jul/31/2020 |
AI-suggested references
| Link | Publication date |
|---|---|
|
Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations
|
Jan/31/2022 |
|
Pharmacophore Modelling-Based Drug Repurposing Approaches for SARS-CoV-2 Therapeutics.
|
May/10/2021 |
